Frank C Brosius

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Clinical Evaluation

Replacement Therapy

Cardiovascular Disease

Top Venues

Clinical journal of the American Society of Nephrology : CJASN

Disease models & mechanisms

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

This page only lists publications with an associated author ORCID identifier.

Publications

Frank C Brosius
Treatment of Non-diabetic Kidney Diseases with SGLT2 Inhibitors. Clinical journal of the American Society of Nephrology : CJASN (2023)
Sarah E Elzinga, Stephanie A Eid, Brett A McGregor, Dae-Gyu Jang, Lucy M Hinder, Jacqueline R Dauch, John M Hayes, Hongyu Zhang, Kai Guo, Subramaniam Pennathur, Matthias Kretzler, Frank C Brosius, Emily J Koubek, Eva L Feldman, Junguk Hur
Transcriptomic analysis of diabetic kidney disease and neuropathy in mouse models of type 1 and type 2 diabetes. Disease models & mechanisms 16 (10) (2023)
Stephanie A Eid, Phillipe D O'Brien, Katharina H Kretzler, Dae Gyu Jang, Faye E Mendelson, John M Hayes, Andrew Carter, Hongyu Zhang, Subramaniam Pennathur, Frank C Brosius, Emily J Koubek, Eva L Feldman
Dietary interventions improve diabetic kidney disease, but not peripheral neuropathy, in a db/db mouse model of type 2 diabetes. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37 (8) (2023)
Frank C Brosius
Treatment of Nondiabetic Kidney Diseases with Sodium-Glucose Cotransporter-2 Inhibitors. Clinical journal of the American Society of Nephrology : CJASN 18 (10) (2023)
Katherine R Tuttle, Frank C Brosius, Matthew A Cavender, Paola Fioretto, Kevin J Fowler, Hiddo J L Heerspink, Tom Manley, Darren K McGuire, Mark E Molitch, Amy K Mottl, Leigh Perreault, Sylvia E Rosas, Peter Rossing, Laura Sola, Volker Vallon, Christoph Wanner, Vlado Perkovic
SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. Diabetes 70 (1) (2020)